These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35193833)

  • 41. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
    Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.
    Kelly SP; Lennon H; Sperrin M; Matthews C; Freedman ND; Albanes D; Leitzmann MF; Renehan AG; Cook MB
    Int J Epidemiol; 2019 Apr; 48(2):464-473. PubMed ID: 30376043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying the Sex-Race/Ethnicity-Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES.
    Cameron NA; Petito LC; McCabe M; Allen NB; O'Brien MJ; Carnethon MR; Khan SS
    J Am Heart Assoc; 2021 Feb; 10(4):e018799. PubMed ID: 33563002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and prostate cancer: epidemiology and clinical implications.
    Buschemeyer WC; Freedland SJ
    Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
    Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
    Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity and prostate enlargement in men with localized prostate cancer.
    Kopp RP; Han M; Partin AW; Humphreys E; Freedland SJ; Parsons JK
    BJU Int; 2011 Dec; 108(11):1750-5. PubMed ID: 21736693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy.
    Park SW; Readal N; Jeong BC; Humphreys EB; Epstein JI; Partin AW; Han M
    Eur Urol; 2015 Aug; 68(2):311-6. PubMed ID: 25088822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study.
    Discacciati A; Orsini N; Andersson SO; Andrén O; Johansson JE; Wolk A
    Br J Cancer; 2011 Sep; 105(7):1061-8. PubMed ID: 21847119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template Biopsy.
    Kryvenko ON; Lyapichev K; Chinea FM; Prakash NS; Pollack A; Gonzalgo ML; Punnen S; Jorda M
    Am J Surg Pathol; 2016 Aug; 40(8):1125-32. PubMed ID: 27158756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance.
    de Cobelli O; Terracciano D; Tagliabue E; Raimondi S; Galasso G; Cioffi A; Cordima G; Musi G; Damiano R; Cantiello F; Detti S; Victor Matei D; Bottero D; Renne G; Ferro M
    Urol Oncol; 2015 May; 33(5):201.e1-8. PubMed ID: 25791753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
    Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
    Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
    Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
    Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study.
    Jochems SHJ; Fritz J; Häggström C; Järvholm B; Stattin P; Stocks T
    Eur Urol; 2023 May; 83(5):422-431. PubMed ID: 35523620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT.
    Mihalcik SA; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Eur Urol Focus; 2018 Jan; 4(1):64-67. PubMed ID: 28753752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
    Asmar R; Beebe-Dimmer JL; Korgavkar K; Keele GR; Cooney KA
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):62-6. PubMed ID: 22907512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.